Cargando…

Management and outcomes of heart failure patients with CKD: experience from an inter‐disciplinary clinic

AIMS: CKD‐HF patients suffer excess hospitalization and mortality, often under‐treated with life‐prolonging medications due to fear of worsening renal function and hyperkalaemia. Yet, role of inter‐disciplinary working in improving therapy is unknown, which this study aims to investigate. METHODS AN...

Descripción completa

Detalles Bibliográficos
Autores principales: Nguyen, Mai, Rumjaun, Samir, Lowe‐Jones, Racquel, Ster, Irina Chis, Rosano, Giuseppe, Anderson, Lisa, Banerjee, Debasish
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7524254/
https://www.ncbi.nlm.nih.gov/pubmed/32652822
http://dx.doi.org/10.1002/ehf2.12796
_version_ 1783588522946461696
author Nguyen, Mai
Rumjaun, Samir
Lowe‐Jones, Racquel
Ster, Irina Chis
Rosano, Giuseppe
Anderson, Lisa
Banerjee, Debasish
author_facet Nguyen, Mai
Rumjaun, Samir
Lowe‐Jones, Racquel
Ster, Irina Chis
Rosano, Giuseppe
Anderson, Lisa
Banerjee, Debasish
author_sort Nguyen, Mai
collection PubMed
description AIMS: CKD‐HF patients suffer excess hospitalization and mortality, often under‐treated with life‐prolonging medications due to fear of worsening renal function and hyperkalaemia. Yet, role of inter‐disciplinary working in improving therapy is unknown, which this study aims to investigate. METHODS AND RESULTS: Clinical, biochemical data, and medications at first and last clinic visit were obtained from patient records for 124 patients seen in kidney failure–heart failure clinic (23 March 2017 to 11 April 2019). Medication dose groups (none, low, and high dose), number of RAASi agents, and blood test results were compared between first and last visit in patients with at least two clinic visits (n = 97). Patient characteristics were age 78.5 years (IQR 68.1–84.4 years), male 67.7%, diabetes 51.6%, moderate (45.2%) vs. severe (39.5%) CKD, HF with reduced ejection fraction (HFrEF) (49.2%), follow‐up 234 days (IQR 121–441 days). HFrEF was associated with increased risk of death (adjusted OR 4.49, 95% CI 1.43–14.05; P = 0.01). Distributions of patients according to number of RAASi agents they were on differed between first and last visit (P = 0.03). Dosage was increased in 25.9% for beta‐blockers, 33.0% for ACEi/ARBs, and 17.5% for MRAs. Distributions of patients across MRA dosage groups was different (P = 0.03), with higher proportions on higher dosages at last visit, without significant changes in serum potassium or creatinine. Serum ferritin improved (131.0 vs. 267.5 μg/L; P < 0.001), and fewer patients had iron deficiency (56.7% vs. 26.8%; P = 0.002) at last visit compared to the first. CONCLUSIONS: This inter‐disciplinary clinic improved guideline‐recommended medication prescription, MRA dosages in CKD‐HF patients without significant biochemical abnormality, and iron status. A prospectively designed study with medication titration protocol and defined patient‐centred outcomes is needed to further assess effectiveness of such clinic.
format Online
Article
Text
id pubmed-7524254
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-75242542020-10-02 Management and outcomes of heart failure patients with CKD: experience from an inter‐disciplinary clinic Nguyen, Mai Rumjaun, Samir Lowe‐Jones, Racquel Ster, Irina Chis Rosano, Giuseppe Anderson, Lisa Banerjee, Debasish ESC Heart Fail Short Communications AIMS: CKD‐HF patients suffer excess hospitalization and mortality, often under‐treated with life‐prolonging medications due to fear of worsening renal function and hyperkalaemia. Yet, role of inter‐disciplinary working in improving therapy is unknown, which this study aims to investigate. METHODS AND RESULTS: Clinical, biochemical data, and medications at first and last clinic visit were obtained from patient records for 124 patients seen in kidney failure–heart failure clinic (23 March 2017 to 11 April 2019). Medication dose groups (none, low, and high dose), number of RAASi agents, and blood test results were compared between first and last visit in patients with at least two clinic visits (n = 97). Patient characteristics were age 78.5 years (IQR 68.1–84.4 years), male 67.7%, diabetes 51.6%, moderate (45.2%) vs. severe (39.5%) CKD, HF with reduced ejection fraction (HFrEF) (49.2%), follow‐up 234 days (IQR 121–441 days). HFrEF was associated with increased risk of death (adjusted OR 4.49, 95% CI 1.43–14.05; P = 0.01). Distributions of patients according to number of RAASi agents they were on differed between first and last visit (P = 0.03). Dosage was increased in 25.9% for beta‐blockers, 33.0% for ACEi/ARBs, and 17.5% for MRAs. Distributions of patients across MRA dosage groups was different (P = 0.03), with higher proportions on higher dosages at last visit, without significant changes in serum potassium or creatinine. Serum ferritin improved (131.0 vs. 267.5 μg/L; P < 0.001), and fewer patients had iron deficiency (56.7% vs. 26.8%; P = 0.002) at last visit compared to the first. CONCLUSIONS: This inter‐disciplinary clinic improved guideline‐recommended medication prescription, MRA dosages in CKD‐HF patients without significant biochemical abnormality, and iron status. A prospectively designed study with medication titration protocol and defined patient‐centred outcomes is needed to further assess effectiveness of such clinic. John Wiley and Sons Inc. 2020-07-11 /pmc/articles/PMC7524254/ /pubmed/32652822 http://dx.doi.org/10.1002/ehf2.12796 Text en © 2020 The Authors. ESC Heart Failure published by John Wiley & Sons Ltd on behalf of the European Society of Cardiology This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Short Communications
Nguyen, Mai
Rumjaun, Samir
Lowe‐Jones, Racquel
Ster, Irina Chis
Rosano, Giuseppe
Anderson, Lisa
Banerjee, Debasish
Management and outcomes of heart failure patients with CKD: experience from an inter‐disciplinary clinic
title Management and outcomes of heart failure patients with CKD: experience from an inter‐disciplinary clinic
title_full Management and outcomes of heart failure patients with CKD: experience from an inter‐disciplinary clinic
title_fullStr Management and outcomes of heart failure patients with CKD: experience from an inter‐disciplinary clinic
title_full_unstemmed Management and outcomes of heart failure patients with CKD: experience from an inter‐disciplinary clinic
title_short Management and outcomes of heart failure patients with CKD: experience from an inter‐disciplinary clinic
title_sort management and outcomes of heart failure patients with ckd: experience from an inter‐disciplinary clinic
topic Short Communications
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7524254/
https://www.ncbi.nlm.nih.gov/pubmed/32652822
http://dx.doi.org/10.1002/ehf2.12796
work_keys_str_mv AT nguyenmai managementandoutcomesofheartfailurepatientswithckdexperiencefromaninterdisciplinaryclinic
AT rumjaunsamir managementandoutcomesofheartfailurepatientswithckdexperiencefromaninterdisciplinaryclinic
AT lowejonesracquel managementandoutcomesofheartfailurepatientswithckdexperiencefromaninterdisciplinaryclinic
AT steririnachis managementandoutcomesofheartfailurepatientswithckdexperiencefromaninterdisciplinaryclinic
AT rosanogiuseppe managementandoutcomesofheartfailurepatientswithckdexperiencefromaninterdisciplinaryclinic
AT andersonlisa managementandoutcomesofheartfailurepatientswithckdexperiencefromaninterdisciplinaryclinic
AT banerjeedebasish managementandoutcomesofheartfailurepatientswithckdexperiencefromaninterdisciplinaryclinic